RxDoctor Payments Data

Robert Hower

Gastroenterology · Erie, PANPI 1053407155

Payments from drug & device makers

$5,358in general payments, 2019–2025

Across 278 payments — averaging $19.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$3K
  • AbbVie$726
  • Boston Scientific$344
  • Ironwood Pharmaceuticals, Inc$297
  • Bristol Myers Squibb$294
  • Takeda Pharmaceuticals U.S.A., Inc.$224
  • plus $361 from 6 others

What the payments were for

  • Food & beverage$5,22197%
  • Education$1373%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,358 in reported general payments places this provider in the 65th percentile of 935 gastroenterology providers in Pennsylvania.

See all gastroenterology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$193,385
Medicare patients
528
Services billed
3,980

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase18$35,342
Mesalamine37$22,204
LinzessLinaclotide22$19,878
Mesalamine DrMesalamine18$6,773
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates82$5,603
Dexlansoprazole DrDexlansoprazole19$5,322
SutabSod Sulf/Pot Chloride/Mag Sulf24$3,801
Colestipol Hcl30$3,458
Pantoprazole Sodium236$2,471
Ursodiol17$2,306
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl199$2,282
Budesonide DrBudesonide12$2,134
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg125$2,128
Omeprazole224$1,837
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl121$1,726

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieCreon, Linzess$726$55,22040 claims
Braintree Laboratories, Inc.Sutab$12$3,80124 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 935 gastroenterology providers in Pennsylvania.

Other gastroenterology in Erie

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →